ZA984845B - New class of cationic transfecting agents for nucleic acids - Google Patents

New class of cationic transfecting agents for nucleic acids

Info

Publication number
ZA984845B
ZA984845B ZA984845A ZA984845A ZA984845B ZA 984845 B ZA984845 B ZA 984845B ZA 984845 A ZA984845 A ZA 984845A ZA 984845 A ZA984845 A ZA 984845A ZA 984845 B ZA984845 B ZA 984845B
Authority
ZA
South Africa
Prior art keywords
transfecting agents
nucleic acids
new class
cationic
cationic transfecting
Prior art date
Application number
ZA984845A
Other languages
English (en)
Inventor
Michael Bessodes
Daniel Scherman
Jean Herscovici
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA984845B publication Critical patent/ZA984845B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
ZA984845A 1997-06-06 1998-06-04 New class of cationic transfecting agents for nucleic acids ZA984845B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9707014A FR2764304B1 (fr) 1997-06-06 1997-06-06 Nouvelle classe d'agents transfectants cationiques des acides nucleiques

Publications (1)

Publication Number Publication Date
ZA984845B true ZA984845B (en) 1998-12-29

Family

ID=9507684

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA984845A ZA984845B (en) 1997-06-06 1998-06-04 New class of cationic transfecting agents for nucleic acids

Country Status (18)

Country Link
EP (1) EP0986568B1 (pt)
JP (1) JP2002504815A (pt)
KR (1) KR20010013312A (pt)
CN (1) CN1259134A (pt)
AT (1) ATE214708T1 (pt)
AU (1) AU737579B2 (pt)
BR (1) BR9809953A (pt)
CA (1) CA2292837A1 (pt)
DE (1) DE69804302T2 (pt)
DK (1) DK0986568T3 (pt)
ES (1) ES2174445T3 (pt)
FR (1) FR2764304B1 (pt)
HU (1) HUP0004577A3 (pt)
NO (1) NO314147B1 (pt)
PL (1) PL337177A1 (pt)
PT (1) PT986568E (pt)
WO (1) WO1998055490A1 (pt)
ZA (1) ZA984845B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020058795A1 (en) * 1997-09-08 2002-05-16 Russ J. Mumper Hydrophobic glycosylamine derivatives, compositions, and methods for use
DE19942864A1 (de) * 1999-09-08 2001-03-15 Knoell Hans Forschung Ev Neue O-(Aminoalkyl)-Derivate von Monosacchariden, Verfahren zu ihrer Herstellung und ihre Verwendung als antibakterielle Mittel
FR2829136B1 (fr) * 2001-08-29 2006-11-17 Aventis Pharma Sa Derives lipidiques d'aminoglycosides
WO2003018603A1 (fr) * 2001-08-29 2003-03-06 Aventis Pharma S.A. Derives lipidiques d'aminoglycosides_pour la transfection
JP5107350B2 (ja) 2005-06-08 2012-12-26 アミカス セラピューティックス インコーポレイテッド イミノおよびアミノ糖の精製
JPWO2008081686A1 (ja) * 2006-12-28 2010-04-30 コニカミノルタホールディングス株式会社 コレステロール誘導体、リポソーム、リポソームの形成方法およびｘ線用造影剤
US10538784B2 (en) * 2016-03-01 2020-01-21 Molecular Transfer, Inc. Plant virus movement proteins and methods of using the same
US11964051B2 (en) * 2018-05-16 2024-04-23 Translate Bio, Inc. Ribose cationic lipids
MA53434A (fr) 2018-08-23 2021-12-01 Seagen Inc Anticorps anti-tigit

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2774417B2 (ja) * 1991-08-07 1998-07-09 株式会社ディ・ディ・エス研究所 ペプチド骨格を有する分枝鎖型糖複合体及び微粒子キャリヤー
DE4329093A1 (de) * 1993-08-30 1995-03-02 Bayer Ag Substituierte Aminoalkylglycoside
AU4923696A (en) * 1995-02-10 1996-08-27 Nexstar Pharmaceuticals, Inc. Lipid constructs for cytoplasmic delivery of agents

Also Published As

Publication number Publication date
ATE214708T1 (de) 2002-04-15
NO995858L (no) 1999-11-30
DK0986568T3 (da) 2002-06-10
BR9809953A (pt) 2000-08-01
NO314147B1 (no) 2003-02-03
CA2292837A1 (fr) 1998-12-10
FR2764304B1 (fr) 1999-07-16
HUP0004577A3 (en) 2003-03-28
EP0986568A1 (fr) 2000-03-22
ES2174445T3 (es) 2002-11-01
PL337177A1 (en) 2000-08-14
JP2002504815A (ja) 2002-02-12
NO995858D0 (no) 1999-11-30
PT986568E (pt) 2002-08-30
FR2764304A1 (fr) 1998-12-11
HUP0004577A1 (hu) 2001-04-28
AU737579B2 (en) 2001-08-23
AU8025098A (en) 1998-12-21
EP0986568B1 (fr) 2002-03-20
WO1998055490A1 (fr) 1998-12-10
DE69804302T2 (de) 2002-10-17
DE69804302D1 (de) 2002-04-25
KR20010013312A (ko) 2001-02-26
CN1259134A (zh) 2000-07-05

Similar Documents

Publication Publication Date Title
PT983087E (pt) Composicao de vacina multivalente com veiculo misto
FR2676072B1 (fr) Vecteur de delivrance d'arn.
AU8711098A (en) Modified low-density lipoprotein receptor
ZA984845B (en) New class of cationic transfecting agents for nucleic acids
IL117459A0 (en) DNA encoding papillomavirus type 18
BE1014502A5 (fr) Compositions pharmaceutiques.
DE69009913T2 (de) Kationische Elektrotauchlackierzusammensetzung.
EP0643038A3 (en) Polyfunctional cationic surfactants, their compositions, processes for their preparation and uses.
DE69818492D1 (en) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele
PH31401A (en) Process for the manufacture of form 1 ranitidine hydrochloride.
DE59505895D1 (de) Verteiler-bzw. Zustellerwagen
DE69807857D1 (de) Antitumorale bisphosphonate mit alkylierenden einheiten
DE9404450U1 (de) Verteiler bzw. Zustellerwagen
ZA983781B (en) Process for the preparation of 1,1,1,3,3-pentachlorobutane.
DE69007944D1 (de) Kationische Elektrotauchlackierung-Zusammensetzung.
IT221657Z2 (it) Sedile ad elevata traspirabilita', ad esempio per autoveicoli.
ITTO910267U1 (it) Supporto per strumenti elettrici o simili, ad esempio per veicoli.
ITBO950251A0 (it) Macchina per l'assemblaggio di mobili
IT232318Y1 (it) Macchina per la preparazione personalizzata di pizze.
ES555466A0 (es) Mejoras introducidas en el objeto de la patente de invencion 516.212 por perfeccionamientos introducidos en atomizadores agricolas
MX9708877A (es) P62, sus variantes, las secuencias de acidos nucleicos que los codifican, y su utilizacion en terapia genica anti-cancerosa.
ITBO970215A1 (it) Calzettone dotato di mezzi per il supporto di parasinchi.
ES511161A0 (es) "perfeccionamientos en las maquinas destinadas al volteo de botellas, frascos o similares".
ZA9811804B (en) 11ß-halogen-7Ó-substituted estratrienes, process for the production of pharmaceutical preparations that contain these 11ß-halogen-7Ó-substituted estratrienes as well as their use for the production of pharmaceutical agents.
IT1292584B1 (it) Macchina per l'ottenimento, mediante tranciatura, di sottopiedi, tallonette e articoli similari.